Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials

Overview of attention for article published in Journal of Hematology & Oncology, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Researchers Report Further Analysis of Zanubrutinib Monotherapy for R/R MCL

AJMC, 13 Nov 2021

In a recent report, researchers reported pooled data from 2 studies to explore the efficacy of zanubrutinib monotherapy in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.